Cite

HARVARD Citation

    Butzkueven, H. et al. (2022). 023  Relapse outcomes with natalizumab Q4W vs switch to Q6W. Journal of neurology, neurosurgery and psychiatry. 93 (6), pp. A20-A21. [Online]. 
  
Back to record